-
Catalent Completes $14M Biologics Packaging Expansion
contractpharma
April 24, 2020
Adds 15,000 square feet of packaging infrastructure to biologics and sterile manufacturing at its Bloomington, IN facility.
-
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
Wuxi Biologics
March 11, 2020
WuXi Biologics announced that it has completed the weather-tight seal of its biologics drug substance manufacturing facility on the Dundalk Campus in Ireland on schedule, which significantly symbolizes the start of the company’s global biomanufacturing ne
-
Biologics and generics reported to save NHS £700m
europeanpharmaceuticalreview
September 03, 2019
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.
-
Biologics or small molecule drugs for rare disease treatment? It is a question
PharmaSources/Miling
July 31, 2019
To both patients and pharmaceutical practitioners, it is a question as to whether to choose biologics or small molecule drugs for rare disease treatment, since the prices are sky-high.
-
GenScript Biotech Opens Biologics R&D and Production Center
contractpharma
July 22, 2019
Meets all U.S., EU and Chinese GMP requirements.
-
Astellas, Seattle Genetics Announce BLA Submission for Enfortumab Vedotin
americanpharmaceuticalreview
July 17, 2019
Astellas Pharma and Seattle Genetics announced submission of a Biologics License Application for accelerated approval to the U.S. Food and Drug Administration for the investigational agent enfortumab vedotin for the ...
-
WuXi Biologics Plans to Further Expand New Bioconjugation Center
contractpharma
June 24, 2019
To include commercial manufacturing in Wuxi City, China.
-
AGC Biologics Appoints New Chief Technical Officer
contractpharma
June 12, 2019
Kasper Møller most recently served as site head for AGC’s Copenhagen facility.
-
WuXi Biologics Inks Strategic LOI with Global Vax Leader
contractpharma
May 29, 2019
WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
-
SGS Opens Biologics Testing Facility in UK
contractpharma
May 29, 2019
Receives Scottish Enterprise grant of £1.7 million, as a contribution towards the company’s £7.6 million investment.